WAYS TO IMPROVE INDICATORS OF SPERMATOGENESIS IN COMPLEX TREATMENT OF MALE INFERTILITY
DOI:
https://doi.org/10.11603/1811-2471.2019.v0.i2.10373Keywords:
infertility, pathospermia, spermogramAbstract
The paper presents the results of a study of changes in sperm indices in patients with impaired spermatogenesis and against the background of treatment with the food additive Xenoderm. As a result of the study, it was revealed that the drug Xenoderm has a high efficacy in the treatment of men with mild violations of the generative function.
The aim – to study the dynamics of changes in semen indices in the treatment of male infertility with Xenoderm.
Material and Methods. To assess the clinical efficacy and safety of a food additive, 21 patients with chronic non-infectious prostatitis and fertility disorders were examined. The study included men aged 21–40 years (mean age 31.4 years) diagnosed with chronic prostatitis and impaired fertility. The disease duration was at least 6 months.
For immunotolerative correction of structural and functional changes in target organs, a tabletting agent was used, made from crushed cryo-lyophilized xenodermal pig substrate, in the form of a food additive Xenoderm produced by the Institute of Biomedical Technologies (Ternopil).
Conclusions. The results of the study indicate the high efficacy of the drug Xenoderm in the treatment of men with mild violations of the generative function, not caused by diseases of the urogenital organs and any form of hypogonadism. Extensive use of the drug Xenoderm should be recommended to improve the reproductive viability of patients with patospermia of marginal and subfertile levels, due to an unexplained cause or associated with an unhealthy lifestyle. It may also be advisable to include the drug Xenoderm in the complex treatment of men with reduced fertility of various etiologies.
References
Gorpinchenko, I.I., Romanenko, O.V., & Nurimanov, K.R. (2004). Analiz gendernykh problem pri supruzheskom besplodii [Analysis of gender problems in marital infertility]. Zdorovye muzhchin – Men's Health, 1, 14-16 [in Russian].
Dedov, I.I., & Kalinchenko, S.Yu. (2006). Vozrastnoy androgennyy defitsit u muzhchin [Age androgen deficiency in men]. Moscow [in Russian].
Kostiev, F.I., & Chystiakov, R.B. (2004). Osoblyvosti patohenezu vtorynnoi cholovichoi neplidnosti [Peculiarities of the pathogenesis of secondary male infertility]. Urolohiia – Urology, 2, 72-76 [in Ukrainian].
Sivkov, A.V., Oshchepkov, V.N., & Yevdokimov, V.V. (2010). Effektivnost i bezopasnost preparata Seltsink Plyus u patsiyentov s khronicheskim neinfektsionnym prostatitom i narusheniyami fertilnosti [The efficacy and safety of Selzink Plus in patients with chronic non-infectious prostatitis and fertility disorders]. Eksperimentalnaya i klinicheskaya urologiya – Experimental and Clinical Urology, 1, 49-54 [in Russian].
Ebisch, I.M., Thomas, C.M., Peters, W.H., Braat, D.D., & Steegers-Theunissen R.P. (2007). The importance of folate, zinc and antioxidants in the pathogenesis and prevention of subfertility. Hum. Reprod. Update, 13 (2), 163-174. DOI: https://doi.org/10.1093/humupd/dml054
Safarinejad, M.R., & Safarinejad, S. (2009). Efficacy of selenium and/or N-acetylcysteine for improving semen parameters in infertile men: a double-blind, placebo controlled, randomized study. J. Urol., 181 (2), 741-751. DOI: https://doi.org/10.1016/j.juro.2008.10.015
Skalnyy, A. V. (2004). Khimicheskiye elementy v fiziologii i ekologii cheloveka [Chemical elements in human physiology and ecology]. Moscow: izdatelskiy dom “ONIKS 21 vek”: Mir [in Russian].
Nikitin, O. D. (2009). Besplodnyy brak v Ukraine: perspektivy i tendentsii [Afetal marriage in Ukraine: prospects and trends]. Zdorovye muzhchiny – Men's Health, 4, 211-215 [in Russian].
Sapsay, V.I., Imshenitskaya, L.P., & Sapsay, V.V. (2005). Muzhskoye besplodiye [Male infertility]. Kyiv: “Avrora plyus” [in Russian].
Barret-Connor, E., Goodman-Gruen, D., & Patay, B. (1999). Endogenous sex hormones and cognitive in older men. J. Clin. Endocrinol. Metab., 84, 3681-3686
